Renal Denervation Improves Hepatic Steatosis in Hypertensive Patients With Metabolic Syndrome

Thrombosis and Stroke

Dual Antiplatelet Therapy in Patients With Metabolic Syndrome After Mild Ischemic Stroke or Transient Ischemic Attack

J Am Heart Assoc

Xia Z, Gao Y, Chen W, Johnston SC, Amarenco P, Bath PM, Wang X, Yan H, Wang T, Yang Y, Zhang Y, Wang M, Jing J, Wang C, Wang Y, Wang Y, Pan Y

doi: 10.1161/JAHA.125.041449

Hypertension

Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension

Hypertension

Rossignol P, Clozel M, Dreier RF, Flack JM, Flamion B, Mann J, Narkiewicz K, Sassi-Sayadi M, Wang JG, Weber M, Schlaich M

doi: 10.1161/HYPERTENSIONAHA.125.25563

Hypertension

Weekend Warrior Physical Activity Pattern and Mortality in Patients With Hypertension: A Prospective Cohort Study From UK Biobank

Hypertension

Zhu R, Chen C, Kuang M, Tai Y, Qin Y, Wu C

doi: 10.1161/HYPERTENSIONAHA.125.25444

Hypertension

Uric-acid predictive performance analysis for subclinical organ damage in essential hypertensive patients

Nutr Metab Cardiovasc Dis

Petramala L, Galardo G, Circosta F, Servello A, Marino L, Caprioni Grasso L, Baratta F, Renna R, Ceccarelli G, Moscucci F, Nardoianni G, Tocci G, Desideri G, Letizia C

doi: 10.1016/j.numecd.2025.104459

Cardiovascular Risk and Diseases

Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III

Cardiovasc Diabetol

Romiti GF, Mei DA, Corica B, Proietti M, Boriani G, Olshansky B, Chao TF, Huisman MV, Lip GYH, GLORIA-AF Investigators

doi: 10.1186/s12933-025-02950-y

Heart Failure

Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK Biobank

Cardiovasc Diabetol

Bertrand A, Zhou X, Lewis A, Monfeuga T, Gupta R, Grau V, Rodriguez B

doi: 10.1186/s12933-025-02788-4

Hypertension

Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension: The NOTIFY-LVH Randomized Clinical Trial

JAMA Cardiol

Berman AN, Hidrue MK, Ginder C, Shirkey L, Kwatra J, O'Kelly AC, Murphy SP, Searl Como JM, Daly D, Sun YP, Curry WT, Del Carmen MG, Blankstein R, Dodson JA, Morrow DA, Scirica BM, Choudhry NK, Januzzi JL Jr, Wasfy JH

doi: 10.1001/jamacardio.2025.0871

Atrial Fibrillation

Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuation

Cardiovasc Diabetol

Meulendijks ER, Fabrizi B, Bruns S, Eringa EC, Hoebe R, van den Boogert T, Wesselink R, Al-Shama RFM, de Vries TAC, Ernault AC, Niessen HWM, van Boven WJP, Driessen AHG, Zbairi I, Zappala P, Dey D, Isgum I, Planken RN, Krul SPJ, de Groot JR

doi: 10.1186/s12933-025-02985-1

Atrial Fibrillation

Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis

Eur Heart J

Raveendra K, Nadarajah R, Larvin H, Farooq M, Haris M, Cutting U, Kang J, Wilkinson C, Dalakoti M, Kotecha D, Lip GYH, Boriani G, Camm AJ, Van Gelder IC, Wu J, Gale CP

doi: 10.1093/eurheartj/ehag021

Related content

Dual Antiplatelet Therapy in Patients With Metabolic Syndrome After Mild Ischemic Stroke or Transient Ischemic Attack

Aprocitentan in Patients With Chronic Kidney Disease and Resistant Hypertension

Weekend Warrior Physical Activity Pattern and Mortality in Patients With Hypertension: A Prospective Cohort Study From UK Biobank

Uric-acid predictive performance analysis for subclinical organ damage in essential hypertensive patients

Cardio-kidney-metabolic complexity in patients with atrial fibrillation: an analysis from the prospective GLORIA-AF registry phase III

Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK Biobank

Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension: The NOTIFY-LVH Randomized Clinical Trial

Patients with persistent atrial fibrillation and metabolic comorbidities have an altered inflammatory state of atrial epicardial adipose tissue, which is linked to CT-attenuation

Non-antiarrhythmic pharmacotherapy in cardio-renal-metabolic disease and incident atrial fibrillation: a trial meta-analysis